C07K 14/70532
B7 molecules
Official title: {B7 molecules, e.g. CD80, CD86}
C07K14/70532 (B7 molecules) appears on 485 US grants and 858 published applications in this corpus.
Search patents in C07K- Granted patents
- 485
- Published applications
- 858
- Assignees
- 396
- Inventors
- 1,427
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 3 | 0 |
| 1997 | 1 | 0 |
| 1998 | 6 | 0 |
| 1999 | 10 | 0 |
| 2000 | 9 | 0 |
| 2001 | 8 | 1 |
| 2002 | 4 | 28 |
| 2003 | 11 | 20 |
| 2004 | 9 | 18 |
| 2005 | 13 | 18 |
| 2006 | 12 | 22 |
| 2007 | 8 | 10 |
| 2008 | 18 | 16 |
| 2009 | 13 | 21 |
| 2010 | 13 | 13 |
| 2011 | 15 | 16 |
| 2012 | 11 | 22 |
| 2013 | 8 | 13 |
| 2014 | 9 | 14 |
| 2015 | 14 | 10 |
| 2016 | 8 | 25 |
| 2017 | 17 | 19 |
| 2018 | 10 | 41 |
| 2019 | 22 | 43 |
| 2020 | 22 | 63 |
| 2021 | 35 | 81 |
| 2022 | 32 | 87 |
| 2023 | 35 | 92 |
| 2024 | 35 | 56 |
| 2025 | 40 | 65 |
| 2026 | 32 | 44 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Chimeric antigen receptor for treatment of cancer29 Sep 2026US 12,747,278 B2Industry-Academic Cooperation Foundation, Yonsei University
- Fusion peptide for treating autoimmune disease11 Aug 2026US 12,703,736 B2Beijing Zeqin Biomedical Co., Ltd
- Variant ICOS ligand immunomodulatory proteins and related compositions and methods28 Jul 2026US 12,692,299 B2Alpine Immune Sciences, Inc.
- PD-L1 analog fusion proteins for antigen specific immunotherapy and methods of use21 Jul 2026US 12,686,709 B2Akston Biosciences Corporation
- Method for producing cell population containing CAR-expressing immune cells14 Jul 2026US 12,679,902 B2BrightPath Biotherapeutics Co., Ltd.
- Lentiviral delivery of anti-cd20 chimeric antigen receptors8 Oct 2026US 2026/0308622 A1
- Ligand discovery and gene delivery via retroviral surface display8 Oct 2026US 2026/0309700 A1Massachusetts Institute of Technology
- Asymmetric circular tandem repeat proteins1 Oct 2026US 2026/0297166 A1Seattle Children's Hospital d/b/a Seattle Children's Research Institute
- Pd-l1 analog fusion proteins for antigen specific immunotherapy and methods of use24 Sep 2026US 2026/0285939 A1Akston Biosciences Corporation
- Engineered artificial antigen presenting cells for tumor infiltrating lymphocyte expansion17 Sep 2026US 2026/0274920 A1Iovance Biotherapeutics, Inc.
Most cited
By later US patents
- Methods for inducing a population of T cells to proliferate using agents which recognize TCR/CD3 and ligands which stimulate an accessory molecule on the surface of the T cells512US 6,352,694 B1Genetics Institute, Inc. · 2002
- Methods for selectively stimulating proliferation of T cells452US 6,534,055 B1Genetics Institute, Inc. · 2003
- Methods of treating HIV infected subjects386US 6,905,680 B2Genetics Institute, Inc. · 2005
- Methods for selectively stimulating proliferation of T cells385US 6,887,466 B2Genetics Institute, Inc. · 2005
- Methods for selectively stimulating proliferation of T cells384US 6,905,681 B1Genetics Institute, Inc. · 2005